Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)

Microbiology Spectrum(2023)10.1128/spectrum.02057-22Source: DataRank Database

Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020) is a research paper published in Microbiology Spectrum (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.11)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

S J Ryan Arends ORCID,Jennifer M Streit ORCID,Ian A. Critchley ORCID,Nicole Cotroneo ORCID,Mariana Castanheira ORCID

Live enrichment

PubMed:36625644 PMC:PMC9927459 OpenAlex:https://openalex.org/W4315435473

Department of Health and Human Services

Grant: HHSO100201800015C

Spero Therapeutics

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.02057-22

publisherhttps://doi.org/10.1128/spectrum.02057-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.02057-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36625644

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9927459

Fields of Study

Urinary Tract Infections ManagementAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyHumansAnti-Bacterial AgentsErtapenemEscherichia coliCeftriaxoneAztreonamTrimethoprim, Sulfamethoxazole Drug CombinationCarbapenemsUrinary Tract InfectionsKlebsiella pneumoniaeHospitalsMicrobial Sensitivity Testsbeta-Lactamases

MeSH Terms

ErtapenemAnti-Bacterial AgentsAztreonambeta-LactamasesCeftriaxoneEscherichia coliHospitalsHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsUrinary Tract InfectionsTrimethoprim, Sulfamethoxazole Drug CombinationCarbapenems

Keywords

NitrofurantoinUrinary systemTrimethoprimSulfamethoxazoleMedicineIntensive care medicineMicrobiologyCiprofloxacinAntibioticsBiologyInternal medicineResistanceSurveillanceGram-negative BacteriaCtx-m

Sustainable Development Goals

SDG 0: Good health and well-being